Skip to content
Park Medi World logo

Park Medi World

PARKHOSPS NSE
₹230.45 +6.81 (+3.05%)
P/E
34.76
View as Markdown
MCP
Close 4 Nov 2026 ₹230.45 +82.50 +55.8% since 17 Dec 2025
Start ₹147.95

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
19.50%
Debt to Equity
0.18
EPS (TTM)
₹6.63
Book Value
₹46.54
Market Cap
—
P/E (TTM)
34.76
P/B
4.95
ROE
16.80%
Dividend Yield
0.00%
EBITDA
₹476 Cr
52W High
₹305.00
52W Low
₹138.10
Day Range
₹223.00 – ₹232.33
Volume
3,39,582

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

Park Medi World peer comparison
Apollo Hospitals
₹8,599.5059.18₹1,22,850 Cr13.040.24%21.20%17.40%₹26,430 Cr₹2,171 Cr
Max Healthcare Institute
₹927.1561.89₹89,301 Cr7.960.22%14.70%14.70%₹8,712 Cr₹1,457 Cr
Manipal Health Enterprises
₹667.2088.96₹86,479 Cr5.340.00%6.64%8.30%₹11,400 Cr₹906 Cr
Aster DM Healthcare
₹719.55117.00₹59,927 Cr14.910.44%11.30%11.60%₹4,876 Cr₹363 Cr
Fortis Healthcare
₹790.6556.96₹59,706 Cr6.030.13%11.20%13.40%₹9,506 Cr₹1,070 Cr
Narayana Hrudayalaya
₹1,931.5048.36₹39,090 Cr7.890.24%20.50%15.50%₹9,072 Cr₹816 Cr
Global Health
₹1,402.0067.76₹37,618 Cr9.520.04%15.20%17.40%₹4,683 Cr₹552 Cr
Park Medi World (this company)
₹230.4534.76₹9,956 Cr4.950.00%16.80%19.50%₹1,756 Cr₹298 Cr
Median 8 companies₹858.9060.54₹59,817 Cr7.930.18%14.95%15.10%₹8,892 Cr₹861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

51 Average

Data confidence 100/100

Category scores

Quality
67
Strong
Returns, margins, earnings quality 22% weight
Valuation
49
Average
Cheap vs sector & own history 24% weight
Growth
61
Good
Sales & profit trajectory 9% weight
Financial Health
47
Average
Solvency, leverage, coverage 9% weight
Momentum
27
Poor
Trend strength, vol-adjusted 12% weight
Ownership
40
Weak
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

1
  • Though the company is reporting repeated profits, it is not paying out dividend

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1054
OscillatorsNeutral252
Moving AveragesStrong Bearish802

Key readings

RSI (14)
41.92
Neutral
MACD (12,26,9)
−11.94
Bullish
SMA (50)
262.60
Bearish
SMA (200)
240.84
Bearish

As of

Analyst Rating

Based on 1 analysts
BUY100%

1 of 1 analyst rates Buy, 0 Hold, 0 Sell.

As of

BUY
1
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y+16.99%
3Y+10.19%
1Y+20.44%

Net profit

Net profit growth by window
5Y+7.94%
3Y+6.32%
1Y+27.44%

Operating cash flow

Operating cash flow growth by window
5Y+8.09%
3Y+18.24%
1Y+53.02%

Operating margin· change in pp

Operating margin growth by window
5Y−13.78 pp
3Y−4.60 pp
1Y−0.27 pp

Trailing twelve months: Fewer than eight quarters are reported, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2021₹766 Cr
Mar 2022₹1,084 Cr
Mar 2023₹1,255 Cr
Mar 2024₹1,231 Cr
Mar 2025₹1,394 Cr
Mar 2026₹1,679 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2021₹187 Cr
Mar 2022₹199 Cr
Mar 2023₹228 Cr
Mar 2024₹152 Cr
Mar 2025₹215 Cr
Mar 2026₹274 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹545 Cr +14.6% vs FY26
Reported High Mean Low

AI Analysis — Bull vs Bear

Generated 6 Aug 2026
AI opinion · based on fundamentals
Risk medium

Park Medi World Ltd is a mid-cap healthcare services company with a market cap of approximately ₹12,396 Cr, trading at a PE of 41.5x. The company delivered FY26 revenue of ₹1,679 Cr (21% YoY growth) and net profit of ₹274 Cr (28% YoY growth), with a 5-year ROE average of 24% and operating margins around 26%. It pays no dividend despite consistent profitability.

Bull Case 7
  • Strong revenue growth of 21% TTM (FY26 revenue ₹1,679 Cr vs ₹1,394 Cr in FY25), accelerating from the 3-year sales CAGR of 10%
  • Net profit grew 28% YoY in FY26 (₹274 Cr vs ₹213 Cr), with TTM profit growth of 25% outpacing sales growth, indicating operating leverage
  • Healthy 5-year average ROE of 24% demonstrates consistent capital efficiency well above cost of equity for the sector
  • Company has reduced debt, with interest costs declining from ₹70 Cr in FY24 to ₹59 Cr in FY26, improving financial flexibility
  • Operating profit margin stable at ~26% in FY26 (₹444 Cr on ₹1,679 Cr revenue), showing pricing power in a competitive healthcare market
  • Q4 FY26 revenue of ₹460 Cr showed 30% YoY growth, suggesting further momentum into FY27
  • 5-year compounded profit growth of 11% with acceleration to 25% TTM signals improving earnings trajectory
Bear Case 7
  • PE of 41.5x is elevated for a healthcare services company with a 3-year profit CAGR of only 5%, implying the stock prices in significant future growth
  • Zero dividend yield despite repeated profitability — no capital return to shareholders even as net profit reached ₹274 Cr in FY26
  • 3-year compounded profit CAGR of only 5% (vs 25% TTM) indicates earnings have been volatile, with FY24 net profit dipping to ₹152 Cr from ₹228 Cr in FY23
  • Tax rate fluctuation (from 30% in FY24 to 23% in FY26) has flattered recent profit growth; normalization could compress earnings
  • OPM declined from 30.7% in FY23 to 26% in FY26, a ~470 bps contraction suggesting rising cost pressures despite topline growth
  • ROE has moderated from 24% (5-year average) to 17% in the last year, pointing to diminishing returns on incremental capital deployed
  • Lack of available 52-week high/low data and limited stock CAGR history suggest relatively thin trading history and potential liquidity risk at ₹12,396 Cr market cap

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

85d ago

TL;DR: Park Medi World is delivering strong earnings growth (35% YoY profit increase) while simultaneously scaling through acquisitions and new hospital launches. The expansion strategy is well-structured with clear bed capacity targets through FY28. No material headwinds are visible in recent news flow. The trend is firmly positive, though execution risk on rapid expansion and integration of acquired assets bears monitoring.

Positives 4
  • Q1FY27 profit up 35% YoY Aug 5

    Net profit rose 35% YoY to ₹886 million for Q1FY27, driven by 19% revenue growth.

  • Dual acquisitions boost scale Aug 3

    Acquired Mehar Hospital for ₹1,070 million and V3 Healthcare for ₹1,770 million, adding capacity and geographic reach.

  • 330-bed Rudrapur hospital launched Aug 2

    Launched The Medicity Hospital in Rudrapur (330 beds), marking entry into Uttarakhand and expanding North India footprint to six states.

Neutral 3
  • IPO proceeds reallocation sought Aug 4

    Postal ballot seeks shareholder approval to redirect ₹648.32 million in unutilised IPO proceeds toward acquiring The Medicity Hospital, Rudrapur. E-voting runs Aug 05–Sep 03, 2026.

  • Investor conferences in August Aug 5

    Management to participate in three investor conferences in Mumbai on August 12, 13, and 25, 2026; no UPSI to be discussed.

  • Q1FY27 earnings call completed Aug 4

    Earnings conference call held on August 4, 2026, discussing unaudited standalone and consolidated Q1FY27 results.

Quarterly Results

₹ Cr
PARKHOSPS quarterly results, ₹ crore
Particulars Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
348
354
399
410
410
460
476
Expenses
265
265
294
297
311
333
350
Operating Profit
83
88
105
113
99
127
126
OPM %
24%
25%
26%
27%
24%
28%
26%
Other Income
15
9
7
8
9
8
8
Interest
16
16
15
15
15
14
10
Depreciation
15
16
15
15
15
18
19
PBT
67
66
82
91
78
103
105
Tax %
32%
20%
20%
14%
32%
26%
16%
Net Profit
46
52
66
79
53
77
89
EPS (₹)
1.19
1.17
1.51
1.91
1.17
1.64
1.91

Profit & Loss

₹ Cr
PARKHOSPS profit and loss, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
766
1,084
1,255
1,231
1,394
1,679
1,756
Expenses
457
740
863
919
1,020
1,233
1,291
Operating Profit
309
345
391
312
374
446
466
OPM %
40%
32%
31%
25%
27%
27%
27%
Other Income
3
9
15
29
30
32
32
Interest
24
40
51
72
62
61
53
Depreciation
24
35
41
51
57
62
67
PBT
265
278
315
218
286
355
378
Tax %
26%
28%
28%
30%
25%
23%
—
Net Profit
187
199
228
152
215
274
297
EPS (₹)
4.03
4.7
5.71
3.99
5.25
5.98
6.63
Div. Payout %
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
PARKHOSPS balance sheet, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
19
77
77
77
77
86
Reserves
256
380
610
806
975
1,936
Borrowings
292
517
576
687
682
364
Other Liabilities
249
319
331
343
393
411
Total Liabilities
816
1,293
1,593
1,912
2,127
2,797
Fixed Assets
365
458
536
837
890
1,309
CWIP
7
29
5
32
37
123
Investments
0
0
0
0
0
0
Other Assets
443
806
1,052
1,043
1,199
1,365
Total Assets
816
1,293
1,593
1,912
2,127
2,797

Cash Flow

₹ Cr
PARKHOSPS cash flow, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
223
155
199
367
215
329
Investing
−233
−248
−234
−76
−100
−316
Financing
49
163
1
−130
−89
121
Net Cash Flow
39
70
−34
161
26
134
Free Cash Flow
86
64
106
299
70
209
CFO/EBITDA
96
72
76
150
80
96

Ratios

PARKHOSPS financial ratios, annual
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
151
151
168
151
161
129
Inventory Days
47
14
3
3
3
4
Days Payable
121
101
110
133
176
134
Cash Conversion Cycle
77
64
61
21
−12
−2
Working Capital Days
40
60
40
21
30
28
ROCE %
—
38%
31%
20%
20%
19%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Park Medi World insights

42 extracted metrics across FY21–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 82.90%
  • DIIs 8.24%
  • Public 4.92%
  • Others 3.06%
  • FIIs 0.88%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Park Medi World

What does Park Medi World Ltd do?
Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.
Where is Park Medi World Ltd (PARKHOSPS) listed?
Park Medi World Ltd trades as PARKHOSPS on the NSE and under code 544645 on the BSE.
Which sector does Park Medi World Ltd belong to?
Park Medi World Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the PE ratio of Park Medi World Ltd?
Park Medi World Ltd trades at a PE ratio of 34.76 as of 4 Nov 2026, on earnings per share of ₹6.63, against a book value of ₹46.54 per share.
What is the 52-week high and low of Park Medi World Ltd?
Over the last 52 weeks Park Medi World Ltd has traded between ₹138.1 and ₹305 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Park Medi World Ltd?
Park Medi World Ltd reported a return on equity of 16.80%. Its debt-to-equity ratio is 0.18.

Company Information

Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.

Website parkhospital.in
Listed 17 Dec 2025
Face Value ₹2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PARKHOSPS.md for Park Medi World Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month